AbstractObjectiveTo describe an approach for reporting master protocol research programs (MPRPs) that is consistent with existing good reporting […]
The late Harvard Business School professor, Clayton Christensen, once described hospitals as “some of the most managerially intractable […]
A drug currently used in just 1% of cancers has significant potential against the remaining 99%, according to […]
Non-small cell lung carcinoma is a particularly aggressive type of lung cancer. Tumor cells and tumor DNA (ctDNA) […]
The nervous system is known to communicate with the immune system and regulate inflammation in the body. Researchers […]
A wider range of health professionals will be legally able to certify fit notes in order to ease […]
The studyHutchinson P, Edlmann E, Bulters D, et al. Trial of dexamethasone for chronic subdural haematoma. N Engl […]
The parliamentary watchdog on public spending has accused the Department of Health and Social Care for England of […]
Patients in the UK with cancer are at risk from “devastating” effects of shortfalls of key radiology and […]
The company completes its enrolment in phase 3 trial evaluating ensifentrine for treatment of COPD